KRP-AM1977X QT/QTc study

KRP-AM1977X Phase I Clinical Study-To assess the effect of KRP-AM1977X on QT/QTc interval in healthy Japanese male subjects-

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222958

Enrollment

Registered

2015-09-07

Start date

2015-09-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

investigational material(s) Generic name etc : KRP-AM1977X INN of investigational material : lascufloxacin Therapeutic category code : 624 Synthetic antibacterials Dosage and Administration for Invest

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: - Japanese healthy adult male - Person with BMI that is more than 18.5 but less than 25.0, etc.

Exclusion criteria

Exclusion criteria: Healthy male subject with an inadequate medical history

Design outcomes

Primary

Measure	Time frame
safety other QTcF ECG	—

Secondary

Measure	Time frame
safety other QTcB ,etc. ECG ,etc.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026